MarketInOut Stock Screener Log In | Sign Up
 

Gilead Sciences Inc

NASDAQ • Healthcare • Drug Manufacturers - General • Quote as of 10/22/2026 16:00
Gilead Sciences Inc stock price and volume chart

Company Profile

IndustryDrug Manufacturers - General
SectorHealthcare
ExchangeNASDAQ
Market Capitalization193,669 mln
Float1,238 mln
Earnings Date10/29/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-4.11
Highly reliable

1-Year Forecast

159.85
Fairly priced

Relative Strength

91 / 100
Top performer

Debt / Equity

2.22
Very high leverage

Pre-Tax Margin

-6%
Marginally loss-making

Business Description

Gilead Sciences is an American drug company founded in 1987 and based in Foster City, California, that researches, develops, and sells treatments for serious diseases with few or no existing options. Its products cover a wide range of conditions, including HIV, hepatitis B and C, COVID-19, dangerous fungal infections, and certain cancers. The company works alongside a number of partner organizations around the world to discover and bring new therapies to patients.

Key Fundamentals

EPS-2.65
ROE-16.32
RPS24.51
ROIC26.41
ROA-5.81
Interest Cover11.95
EBITDA, mln1,782
EV / EBITDA116
EV / EBIT-216
Revenue, mln30,544
EV / Revenue6.76

Quote Details

Last 157.19
Change 3.62 (2.36%)
Open 154.24
Volume 6,154,092
Turnover 967,361,728
Average Volume 5,545,481

Financial Ratios

Pre-Tax Profit Margin-6
Leverage Ratio4.17
Current Ratio1.27
Price / Book15.76
Price / Cash Flow14.33
Price / Free Cash Flow14.40
Debt / Equity2.22
Price / Sales6.13
PEG Ratio3.11

Financial Strength

Altman Z-Score3.68
Piotroski F-Score 5 / 9
Beneish M-Score-4.11
Price to Intrinsic Value1.88
1-Year Target Price159.85
Shiller PE Ratio39.02
Short Ratio3.70
Short % of Float1.76

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.11% 58 / 100   
1 Month 3.84% 86 / 100   
2 Months 17.73% 91 / 100   
6 Months 19.07% 88 / 100   
1 Year 29.82% 85 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog